Trial Profile
A Double-Masked, Randomized, Parallel Group, Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Olopatadine (Primary) ; Fluticasone propionate
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors Alcon
- 12 Mar 2010 Planned number of patients changed from 100 to 130 as reported by ClinicalTrials.gov.
- 23 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 30 Jun 2008 New trial record.